Biotech Medicilon Assist – The IND application for the first new drug NB002 of Neologics Bioscience was approved by the FDA for clinical application Bymedicilon July 27, 2023
Biotech Fudan University, School of Management “Science and Technology Entrepreneur Camp” entered Medicilon: “Hardcore Technology” as the background color, Adding “luster” to new drug research and development Bymedicilon July 27, 2023
Biotech The Medicilon DMPK team was praised again, and Dr. Yan Feng, CEO of Leading Tac Pharma, came to present the award Bymedicilon July 27, 2023
Biotech Another honor! Medicilon won the “Top 50 Chinese Pharmaceutical R&D” in 2022-2023 Bymedicilon July 17, 2023
Biotech Medicilon topped the “Top 10 Most Influential CRO Enterprises” in the 2023 China Biopharmaceutical Industry Value List Bymedicilon July 17, 2023
Biotech Medicilon and EyeCure reached a strategic collaboration to facilitate the preclinical research and development of ophthalmic cell and gene drugs Bymedicilon July 17, 2023
Biotech Five times in a row! Medicilon was shortlisted in the “2022 China CXO Enterprises Top 20 List” Bymedicilon July 17, 2023
Biotech CRO joins with technical companies to promote the transformation of innovative drug research and development, Medicilon and SciMatchmaker reached a strategic collaboration Bymedicilon July 17, 2023
Biotech Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division Bymedicilon July 12, 2023
